FABRAZYME agalsidase beta - rch 5.5mg powder for injection vial

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9d546c63d029bb03
Product Name: FABRAZYME agalsidase beta - rch 5.5mg powder for injection vial
Artg Id: 94000
Artg Name: FABRAZYME agalsidase beta - rch 5.5mg powder for injection vial
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2003-04-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9850611c3eb31fb3861c62eb40c55a5f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7d1e1c28c833b2b6f61b41863282a8d4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

9d546c63d029bb03

Type

Standard